Biopharma, medtech and diagnostics firms raised 51% more Series A money in the first half of 2015 than during the same period last year. According to data from Informa’s Strategic Transactions, they secured $950 million, compared with $627.5 million in H1 2014. There were also more deals overall: Series A volume was up 65% for the period (56 rounds closed versus 34 last year). (See Exhibit 1.)(See[A#2015900014]and Also see "Series A Rounds H1 2014: Fewer Deals, Comparable Money" - Scrip, 8 September, 2014..)
Series A Deal Volume And Money Up In H1
Biopharma, medtech and diagnostics start-ups raised a whopping 51% more Series A money in the first half of 2015 than during the same period last year, and the number of deals was way up too.